Clinical trial
Ruxolitinib Cream in the Treatment of Cutaneous Necrobiosis Lipoidica
NCT04492618 is registered in ClinicalTrials.gov with Aaron R. Mangold as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ruxolitinib Cream in the Treatment of Cutaneous Necrobiosis Lipoidica
- Lead sponsor
- Aaron R. Mangold
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 29, 2020
- Completion date
- March 16, 2022
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.